Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NCBR Investment Fund ASI S.A. is a co-investment venture capital fund located in Warsaw, Poland. Established as part of the National Centre for Research and Development, which operates under the Ministry of Science and Higher Education, the fund specializes in investing in small and medium-sized enterprises (SMEs) that are in the growth or expansion phase. NCBR focuses on companies that are commercializing results from research and development activities. The fund has an investment budget of 700 million PLN, equivalent to approximately $150 million, with individual transaction values ranging from 3 million PLN to 15 million EUR.
Since its inception, NCBR has aimed to support the transition of SMEs from early-stage development to market-ready solutions. The fund's strong backing from the Polish government enhances its ability to foster innovation and facilitate connections between portfolio companies and Polish research institutions. NCBR's commitment to supporting technological advancements is evident in its active investment strategy, which targets sectors such as biotech, AI, fintech, healthcare, and food-agtech.
NCBR Investment Fund ASI S.A. primarily invests in small and medium-sized enterprises (SMEs) that are transitioning from seed and startup stages to growth and expansion. The fund specifically targets companies involved in the commercialization of research and development projects. Eligible portfolio companies must be classified as micro, small, or medium enterprises, have been operating for no longer than seven years since their first commercial sale, and be based in Poland or other OECD countries.
The fund's investment strategy encompasses a wide range of sectors, including biotech, AI, fintech, healthcare, and food-agtech. NCBR's check sizes range from $800,000 to $16 million, allowing for significant support of innovative companies. The fund's focus on co-investment enables it to collaborate with other investors, enhancing the financial backing available to its portfolio companies. NCBR's emphasis on R&D commercialization aligns with its mission to drive technological advancements and support SMEs in achieving market readiness.
NCBR Investment Fund ASI S.A. has built a notable portfolio of companies that exemplify its focus on innovation and R&D commercialization. Key portfolio companies include:
These companies reflect NCBR's commitment to supporting technological advancements across various sectors, including biotech and AI. The fund's strategic focus on SMEs in growth phases positions it as a key player in the European venture capital landscape.
Piotr Sieradzan - President: Piotr has extensive experience in venture capital and investment management, focusing on supporting innovative SMEs. His leadership at NCBR emphasizes the importance of R&D commercialization.
Marcin Syposz - Board Member: Marcin brings a wealth of knowledge in finance and strategic development, contributing to NCBR's mission of fostering innovation in the Polish market.
To pitch NCBR Investment Fund ASI S.A., founders should visit their website at nifasi.pl. It is recommended to include a comprehensive pitch deck that outlines the business model, market analysis, and financial projections. NCBR prefers detailed applications that demonstrate a clear understanding of the commercialization process.
Response times may vary, but founders should expect a thorough review process given the fund's focus on R&D commercialization. Warm introductions can be beneficial, particularly from industry contacts or existing portfolio companies.
As of March 2023, NCBR Investment Fund ASI S.A. has made significant strides in expanding its portfolio, with recent investments in companies like IMAGENE.ME and Digital First AI. These additions highlight the fund's commitment to supporting technological advancements in sectors such as biotech and AI.
In addition to its investment activities, NCBR continues to strengthen its ties with Polish research institutions, enhancing its ability to facilitate the commercialization of innovative technologies.
What are the investment criteria for NCBR Investment Fund ASI S.A.?
NCBR targets small and medium-sized enterprises (SMEs) that are transitioning from seed and startup stages to growth and expansion. Eligible companies must be classified as micro, small, or medium enterprises, have been operating for no longer than seven years since their first commercial sale, and be based in Poland or other OECD countries.
How can startups apply or pitch to NCBR?
Startups can pitch to NCBR Investment Fund ASI S.A. through their official website at nifasi.pl. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes NCBR Investment Fund ASI S.A. different from other venture capital firms?
NCBR is a government-backed fund that focuses on co-investment in SMEs, particularly those commercializing research and development results. Its affiliation with the National Centre for Research and Development provides unique access to resources and expertise in R&D.
What is the geographic scope of NCBR's investments?
NCBR primarily invests in companies based in Poland or other OECD countries, focusing on SMEs that are involved in R&D commercialization.
What is the typical check size for investments?
NCBR Investment Fund ASI S.A. typically invests between $800,000 and $16 million in its portfolio companies, depending on the specific needs and growth stage of the business.
What kind of post-investment involvement does NCBR have?
NCBR provides not only financial support but also access to a network of resources and expertise in research and development, facilitating connections with Polish research institutions to enhance the commercialization process for innovative technologies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.